Baduanjin Training for Depression and Anxiety Patients
Effects of Baduanjin Breathing Training for Depression and Anxiety Patients: a Prospective Randomized Study
1 other identifier
interventional
120
1 country
1
Brief Summary
In recent years, the number of people with symptoms of depression or anxiety are on the rise. The aims of the prospective randomized study are: (1) to examine the effects of Baduanjin breathing training on reducing symptoms of depression or anxiety, and (2) to explore the correlates between improvements of depression or anxiety symptom and changes of lung functions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 17, 2022
CompletedFirst Posted
Study publicly available on registry
October 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2027
April 29, 2026
April 1, 2026
5.5 years
October 17, 2022
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
17-item Hamilton Depression Rating Scale
The HAMD-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression.
Change from Baseline HAMD-17 at 16 weeks
14-item Hamilton Anxiety Rating Scale
The HAMA-14 is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety.
Change from Baseline HAMA-14 at 16 weeks
Secondary Outcomes (9)
Depression, Anxiety and Stress Scale-21 item
Change from Baseline DASS-21 at 8 weeks
Depression, Anxiety and Stress Scale-21 item
Change from 8 weeks DASS-21 at 16 weeks
Vital capacity
Change from Baseline VC at 16 weeks
Forced vital capacity
Change from Baseline FVC at 16 weeks
FVC percentage of predicted normal values
Change from Baseline FVC% at 16 weeks
- +4 more secondary outcomes
Study Arms (2)
Baduanjin intervention group
EXPERIMENTALParticipants randomized to Baduanjin intervention group receive health education plus a Baduanjin training program. The Baduanjin training program was a 16-week, instructor-led group training program that offers breathing training as a core skill.
Health education control group
ACTIVE COMPARATORParticipants randomized to the health education control group only receive health education and no additional training program.
Interventions
The Baduanjin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 16-weeks. All sessions included 10 min of warmup and 10 min of cooldown.
Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.
Eligibility Criteria
You may qualify if:
- Subject with depression or anxiety symptom diagnosed by ICD-10.
- Depression 7≤HAMD-17≤29,anxiety 7≤HAMA-14≤29.
- Subject has a clear mind and the ability to read, to talk and to communicate.
- Subject agrees to participate in this study and sign to the informed consent.
You may not qualify if:
- Subject with bipolar disorder, psychotic disorder, organic mental disorder and cognitive disorder.
- Subject with alcohol abuse, substance dependence and suicidal behavior in past-year.
- Subject has severe somatic disease.
- Subject is pregnant or lactating women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Qigong Research Institute
Shanghai, Shanghai Municipality, 021, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xiaoting Zhao
Shanghai Qigong Research Institute
- PRINCIPAL INVESTIGATOR
Ying Lu
Shanghai Qigong Research Institute
- STUDY DIRECTOR
Jie Li
Shanghai University of Traditional Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessors were blinded to the group allocation of the participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate
Study Record Dates
First Submitted
October 17, 2022
First Posted
October 21, 2022
Study Start
July 1, 2021
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
July 30, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04